| A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants (NCT06589726) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2024-09-10 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers (NCT06780254) | Vespina Lifesciences Inc. | 2024-09-09 |
| Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects (NCT06584812) | Tianjin Institute of Pharmaceutical Research Co., Ltd | 2024-09-09 |
| Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity (NCT06585462) | Amgen | 2024-09-09 |
| EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors (NCT06525298) | Eisbach Bio GmbH | 2024-09-09 |
| Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric Population (NCT06538584) | University of Chicago | 2024-09-09 |
| BF844 Safety and Pharmacokinetic Study in Healthy Volunteers (NCT06592131) | EyeXCel Pty. Ltd. | 2024-09-09 |
| Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects (NCT06852092) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-09 |
| Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes (NCT05696366) | University of California, San Diego | 2024-09-09 |
| Evaluation of Ascorbate-Meglumine Therapeutic for SRS (NCT06433791) | LadeRx LLC | 2024-09-09 |
| A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006) (NCT06567002) | Merck Sharp & Dohme LLC | 2024-09-09 |
| A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers (NCT06376253) | Novartis Pharmaceuticals | 2024-09-08 |
| Clinical Trial of PCV24 in Children Aged 2-17 Years (NCT06550830) | Sinovac Life Sciences Co., Ltd. | 2024-09-07 |
| Anorectal Manometery in Pediatric Chronic Refractory Constipation (NCT06543979) | Ain Shams University | 2024-09-07 |
| A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT06256484) | Atara Biotherapeutics | 2024-09-06 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. (NCT06476808) | Bristol-Myers Squibb | 2024-09-06 |
| A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants (NCT06533475) | UCB Biopharma SRL | 2024-09-06 |
| A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. (NCT06546553) | Pfizer | 2024-09-06 |
| A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas (NCT06248086) | Astellas Pharma Global Development, Inc. | 2024-09-06 |
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants (NCT06606106) | Eli Lilly and Company | 2024-09-05 |
| A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. (NCT06393738) | Arvinas Inc. | 2024-09-05 |
| Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression (NCT06898606) | Federal University of Latin American Integration | 2024-09-05 |
| Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets (NCT06248801) | Bio-innova Co., Ltd | 2024-09-05 |
| Study of TTX-MC138 in Subjects With Advanced Solid Tumors (NCT06260774) | TransCode Therapeutics | 2024-09-05 |
| A Comparative Evaluation of Pharmacokinetics and Immunogenicity. (NCT06918587) | Kashiv BioSciences, LLC | 2024-09-05 |
| Study of Tazemetostat in Lymphoid Malignancies (NCT05983965) | University of Alabama at Birmingham | 2024-09-05 |
| A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer (NCT06631989) | Wayshine Biopharm, Inc. | 2024-09-04 |
| A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088 (NCT06579300) | AbbVie | 2024-09-04 |
| Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers (NCT07095049) | Interna Therapeutics Ltd. | 2024-09-04 |
| A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants (NCT06547554) | Qpex Biopharma, Inc. | 2024-09-04 |
| 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer (NCT06414902) | M.D. Anderson Cancer Center | 2024-09-04 |
| Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma. (NCT06482905) | Tcelltech Inc. | 2024-09-04 |
| Study of AXT-1003 in Subjects With Advanced Malignant Tumors. (NCT06484985) | Axter Therapeutics (Beijing) Co., Ltd | 2024-09-04 |
| Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects (NCT06701110) | Shanghai Jiatan Pharmatech Co., Ltd | 2024-09-04 |
| A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants (NCT06554574) | Latigo Biotherapeutics | 2024-09-03 |
| A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha (NCT06547840) | Epsilogen Ltd | 2024-09-03 |
| Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias (NCT06364423) | National Cancer Institute (NCI) | 2024-09-03 |
| Stem Cell Treatment for Regeneration of the Rotator Cuff (Lipo-Cuff Study) (NCT06505135) | University of Southern Denmark | 2024-09-03 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects (NCT06573528) | Cascade Pharmaceuticals, Inc | 2024-09-03 |
| Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants (NCT06577259) | Bristol-Myers Squibb | 2024-09-03 |
| A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers (NCT06567392) | Chengdu Suncadia Medicine Co., Ltd. | 2024-09-03 |
| Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets (NCT06233162) | Bio-innova Co., Ltd | 2024-09-03 |
| A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity (NCT06577766) | Novo Nordisk A/S | 2024-09-03 |
| Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma (NCT07648069) | Sun Yat-sen University | 2024-09-03 |
| A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009) (NCT06575933) | Merck Sharp & Dohme LLC | 2024-09-03 |
| Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion (NCT07587619) | University of Southern California | 2024-09-03 |
| Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome (NCT06283355) | Johns Hopkins University | 2024-09-03 |
| Heat Therapy in Type 2 Diabetes (NCT06596967) | Purdue University | 2024-09-03 |
| Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus (NCT06591884) | Hospital de Clinicas de Porto Alegre | 2024-09-03 |
| Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture (NCT06604832) | Kalpna Kay Durairaj, MD, FACS | 2024-09-03 |
| First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors (NCT06554795) | DualityBio Inc. | 2024-09-03 |
| Denosumab for Type 1 Diabetes (NCT06524960) | City of Hope Medical Center | 2024-09-03 |
| A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma (NCT06381141) | Cullinan Therapeutics Inc. | 2024-09-03 |
| Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation (NCT06905847) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-02 |
| A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease (NCT06480461) | Shanghai Vitalgen BioPharma Co., Ltd. | 2024-09-02 |
| Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke (NCT06612359) | Hasselt University | 2024-09-02 |
| Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis (NCT06553209) | Keymed Biosciences Co.Ltd | 2024-09-02 |
| Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients (NCT06560489) | Shanxi Kangbao Biological Product Co., Ltd. | 2024-09-02 |
| A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults (NCT06360640) | AdjuTec Pharma AS | 2024-09-02 |
| To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107 (NCT06816719) | JW Pharmaceutical | 2024-09-02 |
| A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants (NCT06576271) | GlaxoSmithKline | 2024-09-02 |
| Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry (NCT06577597) | GlaxoSmithKline | 2024-09-02 |
| Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer (NCT06283719) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-09-02 |
| The Purpose of the Study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407 (NCT06536101) | Georgiamune Inc | 2024-09-02 |
| "Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL (NCT06559553) | Mingzhi Zhang | 2024-09-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 (NCT06331728) | IgGenix Australia Pty Ltd | 2024-09-01 |
| Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers (NCT06607770) | Zhou Chengzhi | 2024-09-01 |
| Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD (NCT06568328) | Fujian Medical University | 2024-09-01 |
| JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases (NCT06567080) | RenJi Hospital | 2024-09-01 |
| A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers (NCT06518122) | Hanmi Pharmaceutical Company Limited | 2024-09-01 |
| Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A (NCT04418414) | Expression Therapeutics, LLC | 2024-09-01 |
| Pilot Study on the Effectiveness of a Flexible Hydroxyapatite-Based Composite for Jaw Bone Regeneration (NCT06552715) | University of Bologna | 2024-09-01 |
| Golidocitinib Plus CHOP in Newly Diagnosed PTCL (NCT06739265) | Peking Union Medical College Hospital | 2024-09-01 |
| Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL (NCT05114837) | Masonic Cancer Center, University of Minnesota | 2024-09-01 |
| Studying Topiramate for Re-Activating the HIV-1 Reservoir (NCT06282783) | Erasmus Medical Center | 2024-09-01 |
| The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. (NCT04181359) | University of Alberta | 2024-09-01 |
| Niraparib and Temozolomide in Patients Glioblastoma (NCT06258018) | Armando Santoro, MD | 2024-09-01 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel With Coranally Advanced Flap in the Gingival Recession (NCT07437885) | Ordu University | 2024-09-01 |
| Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds (NCT06134843) | Hobart W. Harris | 2024-09-01 |
| A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) (NCT06025344) | TrippBio, Inc. | 2024-09-01 |
| Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia (NCT06370598) | Technophage, SA | 2024-09-01 |
| Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases (NCT07085676) | Polina Stepensky | 2024-09-01 |
| Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer (NCT06513455) | Harbin Medical University | 2024-09-01 |
| Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics (NCT06268964) | Universidad de Colima | 2024-09-01 |
| CelAgace™ OraRinse Solution for Treatment of Candidiasis (NCT03250923) | CelaCare Technologies, Inc. | 2024-09-01 |
| Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy (NCT06880029) | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 2024-09-01 |
| A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors (NCT06992687) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-09-01 |
| Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens (NCT06572319) | Zhejiang Cancer Hospital | 2024-09-01 |
| Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy (NCT07551037) | Fujian Medical University Union Hospital | 2024-09-01 |
| Effect of Gamma-cyclodextrin on the Bioavailability of Berberine (NCT04918667) | EuroPharma, Inc. | 2024-09-01 |
| Phase 1 Trial of KH801 (NCT06364501) | Beijing Kanghong Biopharmaceutical Co., Ltd. | 2024-09-01 |
| Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD (NCT06299319) | Centre for Addiction and Mental Health | 2024-09-01 |
| Tolerability of MDMA in Schizophrenia (NCT05770375) | Anya Bershad, MD, PhD | 2024-09-01 |
| Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy (NCT06553157) | Minia University | 2024-09-01 |
| A Safety and Efficacy Study of Allogeneic CAR Gamma-Delta T Cells in Subjects with Relapsed/Refractory Solid Tumors (NCT06150885) | Ever Supreme Bio Technology Co., Ltd. | 2024-09-01 |
| An Evaluation of the Effect of Food on the PK of a Novel PanCytoVir™ Suspension (100mg/ml), in Healthy, Adult Volunteers (NCT06025318) | TrippBio, Inc. | 2024-09-01 |
| Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis (NCT06788158) | Instituto Mexicano del Seguro Social | 2024-09-01 |
| Lentiviral Gene Therapy for Epilepsy (NCT04601974) | University College, London | 2024-09-01 |
| Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients (NCT06578000) | NOUR ALI ABO EL ELAA FRAGHLY | 2024-09-01 |
| Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers (NCT06585059) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-09-01 |